AXIM - AXIM Biotechnologies, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue47.57347.05949.139-
Cost of Revenue42.857154.1350.387-
Gross Profit4.716-107.071-1.248-
Operating Expenses
Research Development1,352.969235.579571.455571.455
Selling General and Administrative1,797.4783,413.4569,475.724505.729
Non Recurring----
Others----
Total Operating Expenses3,196.663,806.52110,098.685505.729
Operating Income or Loss-3,149.087-3,759.462-10,049.546-505.729
Income from Continuing Operations
Total Other Income/Expenses Net-1,019.116-2,050.444-43.221-32.522
Earnings Before Interest and Taxes-3,149.087-3,759.462-10,049.546-505.729
Interest Expense-1,020.713-301.446-43.221-32.522
Income Before Tax-4,168.203-5,809.906-10,092.767-538.251
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-4,168.203-5,809.906-10,092.767-538.251
Non-recurring Events
Discontinued Operations----44.696
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-4,168.203-5,809.906-10,092.767-582.947
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-4,168.203-7,284.906-10,092.767-582.947